T A Splinter|T C Kok - JoVE Visualize

Showing results (61-70 of 103) with videos related to

Pageof 11

Sort By:

British Journal of Cancer|September 1, 1985

Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancerE H Cooper, T A Splinter, D A Brown, et al.

European Journal of Cancer (Oxford, England : 1990)|June 1, 1996

Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: prognostic factor analysisT A Splinter, M Pavone-Macaluso, D Jacqmin, et al.

Cancer|October 1, 1978

Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histologyA A Bom-Van Noorloos, T A Splinter, P van Heerde, et al.

Endoscopy|November 1, 1993

Assessment of response of esophageal carcinoma to induction chemotherapyM L Hordijk, T C Kok, J H Wilson, et al.

The Netherlands Journal of Surgery|August 1, 1991

Local treatment of liver metastases with recombinant tumour necrosis factor (rTNF): a phase one studyJ N IJzermans, G P van der Schelling, M Scheringa, et al.

The Journal of Urology|December 1, 1992

A European Organization for Research and Treatment of Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-XM0 transitional cell cancer of the bladder: evaluation of clinical responseT A Splinter, M Pavone-Macaluso, D Jacqmin, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1990

Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous systemJ W Moll, S C Henzen-Logmans, T A Splinter, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1989

Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practiceT A Splinter, D N Carney, M Teeling, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative GroupA S Planting, T A Splinter, A Ardizzoni, et al.

Clinical Lung Cancer|January 21, 2004

Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941T A Splinter, P E van Schil, G W Kramer, et al.

Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:

Pageof 11

British Journal of Cancer|September 1, 1985

Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancerE H Cooper, T A Splinter, D A Brown, et al.

European Journal of Cancer (Oxford, England : 1990)|June 1, 1996

Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: prognostic factor analysisT A Splinter, M Pavone-Macaluso, D Jacqmin, et al.

Cancer|October 1, 1978

Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histologyA A Bom-Van Noorloos, T A Splinter, P van Heerde, et al.

Endoscopy|November 1, 1993

Assessment of response of esophageal carcinoma to induction chemotherapyM L Hordijk, T C Kok, J H Wilson, et al.

The Netherlands Journal of Surgery|August 1, 1991

Local treatment of liver metastases with recombinant tumour necrosis factor (rTNF): a phase one studyJ N IJzermans, G P van der Schelling, M Scheringa, et al.

The Journal of Urology|December 1, 1992

A European Organization for Research and Treatment of Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-XM0 transitional cell cancer of the bladder: evaluation of clinical responseT A Splinter, M Pavone-Macaluso, D Jacqmin, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1990

Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous systemJ W Moll, S C Henzen-Logmans, T A Splinter, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1989

Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practiceT A Splinter, D N Carney, M Teeling, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative GroupA S Planting, T A Splinter, A Ardizzoni, et al.

Clinical Lung Cancer|January 21, 2004

Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941T A Splinter, P E van Schil, G W Kramer, et al.

Pageof 11